Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 35.50
+0.20 (0.57%)
Jun 18, 2026, 1:30 PM CST
TPE:1762 Market Cap
TPE:1762 has a market cap or net worth of 2.73 billion as of June 18, 2026. Its market cap has increased by 20.16% in one year.
Market Cap
2.73B
Enterprise Value
3.25B
Revenue
973.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.50
Market Cap Chart
Since December 10, 2009, TPE:1762's market cap has decreased from 5.27B to 2.73B, a decrease of -48.14%. That is a compound annual growth rate of -3.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.73B | 44.90% |
| Dec 31, 2025 | 1.88B | -28.33% |
| Dec 31, 2024 | 2.63B | -40.94% |
| Dec 29, 2023 | 4.45B | -12.50% |
| Dec 30, 2022 | 5.09B | 1.08% |
| Dec 30, 2021 | 5.03B | 5.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.23B |
| Energenesis Biomedical CO.,LTD. | 3.22B |
| Shine-On BioMedical | 3.15B |
| BioGend Therapeutics | 3.10B |
| BRIM Biotechnology | 2.98B |
| Apex Biotechnology | 2.93B |
| Genovate Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.85B |